The Chemours Company (NYSE:CC) Q1 2025 Earnings Call Transcript
Operator: Good morning. My name is Michelle, and I will be your conference operator today.
Chemours Co (CC)
Market is closed
Sector: Chemicals & Allied Products
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Easterly Partners John Murphy | 59,831 | $809,513 | 0.07% | |
| 2. | Bourgeon Capital John Zaro | 34,000 | $460,020 | -23% | 0.1% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 22,393 | $302,977 | 0% | |
| 4. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.63 | 7,661 | Officer, Director | 266,955 | 2023-06-09 | Filing | |
| $34.63 | 7,661 | Officer, Director | 266,955 | 2023-06-09 | Filing | |
| $11.62 | 1,000 | Officer | 133,344 | 2020-05-07 | Filing | |
| $11.62 | 1,500 | Officer | 132,344 | 2020-05-07 | Filing | |
| $10.15 | 11,000 | Officer | 141,891 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.64 | 7,500 | Officer | 16,645 | 2024-11-07 | Filing | |
| $18.84 | 1,108 | Officer | 19,890 | 2024-08-07 | Filing | |
| $18.81 | 1,576 | Officer | 20,998 | 2024-08-07 | Filing | |
| $19.04 | 73 | Officer | 22,574 | 2024-08-06 | Filing | |
| $32.30 | 5,125 | Officer | 13,890 | 2023-06-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,656,076 | $293,006,707 | 0.01% | |
| 2. | 16,487,008 | $223,069,213 | 0% | |
| 3. | 1,555,403 | $21,044,603 | 0.01% | |
| 4. | 1,438,732 | $19,466,044 | 0% | |
| 5. | 1,246,269 | $16,862,021 | 0% |
News See All
11 Best Breakout Stocks to Buy According to Analysts
Stock markets have been on edge in response to the US President's aggressive trade war that has resulted in trade tariffs aimed at settling the trade deficit.
11 Most Promising Small-Cap Stocks According to Analysts
Robert Teeter of Silvercrest Asset Management recently appeared in an interview to express that he thinks small-cap stocks are currently facing a choppy market, but he also acknowledged that he anticipates...
11 Best Mid-Cap Value Stocks to Buy According to Analysts
Value investing remains a time-tested strategy that provides both stability and long-term growth, particularly during periods of market volatility and elevated stock valuations.
11 Stocks That Will Go to the Moon According to Reddit
Saira Malik, Nuveen's Head of Equities and Fixed Income, recently joined CNBC's 'Closing Bell' on February 18 to discuss opportunities outside the tech sector and her outlook for the markets.
The Chemours Company (NYSE:CC) Q4 2024 Earnings Call Transcript
Operator: Good morning. My name is Michelle, and I will be your conference operator today. I would like to welcome everyone to The Chemours Company Fourth Quarter 2024 Results Conference Call.
These Were Last Week's 10 Worst Dividend Stocks
Dividend stocks have historically been the top preference for many investors seeking stable income.
12 Best Basic Materials Stocks to Buy According to Analysts
Fitch Ratings sees a stable demand environment for North American building products and materials companies heading into 2025.
Chemours Company (NYSE:CC): A Bullish Investment Perspective
We came across a long thesis on Chemours Company (NYSE:CC) on ValueInvestorsClub by Glory_Warriors. In this article we will summarize the bulls’ thesis on CC.
Here’s Buckley Capital’s Updates on Chemours (CC)
Buckley Capital Advisors, an investment management company, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
